CAS 953769-46-5

4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-2-pyridinecarboxamide

CAS: 953769-46-5

Formel: C₂₀H₂₂N₄O₃S

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 398.4787

Ref: IN-DA00368U

Sotuletinib

CAS: 953769-46-5

Sotuletinib

Reinheit: ≥95%

Molekulargewicht: 398.48g/mol

Ref: 54-BUP15067

4-((2-(((1R,2R)-2-Hydroxycyclohexyl)Amino)Benzo[D]Thiazol-6-Yl)Oxy)-N-Methylpicolinamide

CAS: 953769-46-5

4-((2-(((1R,2R)-2-Hydroxycyclohexyl)Amino)Benzo[D]Thiazol-6-Yl)Oxy)-N-Methylpicolinamide

Reinheit: 98%

Molekulargewicht: 398.48g/mol

Ref: 54-OR1024387

BLZ-945

CAS: 953769-46-5

Formel: C₂₀H₂₂N₄O₃S

Reinheit: ≥ 98.0%

Farbe und Form: White to off-white powder

Molekulargewicht: 398.5

Ref: 7W-GL2252

Sotuletinib

CAS: 953769-46-5

Sotuletinib (BLZ945) is an orally active, effective and specific CSF-1R inhibitor, >1000-fold selective against its closest receptor tyrosine kinase homologs.

Formel: C₂₀H₂₂N₄O₃S

Reinheit: 97.43% - 99.82%

Farbe und Form: Solid

Molekulargewicht: 398.48

Ref: TM-T6119

4-((2-(((1R,2R)-2-HYDROXYCYCLOHEXYL)AMINO)BENZO[D]THIAZOL-6-YL)OXY)-N-METHYLPICOLINAMIDE

CAS: 953769-46-5

Formel: C₂₀H₂₂N₄O₃S

Reinheit: 98%

Molekulargewicht: 398.48

Ref: 10-F501110

BLZ 945

CAS: 953769-46-5

BLZ 945 is a novel small molecule that inhibits the activation of microglia, which are immune cells in the brain. It has been shown to inhibit tumor growth and radiation-induced tissue damage in cancer research. BLZ 945 also reduces the severity of autoimmune diseases by inhibiting the production of pro-inflammatory cytokines such as csf-1r and toll-like receptor 4. In addition, it has anti-inflammatory properties due to its inhibition of macrophage migration and adhesion. The drug has been shown to reduce the size of solid tumours in mice by reducing tumor angiogenesis and inhibiting cell proliferation.

Formel: C₂₀H₂₂N₄O₃S

Reinheit: Min. 95%

Molekulargewicht: 398.48 g/mol

Ref: 3D-BB178452